Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (109K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ren, S
Right arrow Articles by Atweh, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, S
Right arrow Articles by Atweh, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1996 Oxford University Press 342-348

Footnote

CACCC and GATA-1 sequences make the constitutively expressed [alpha]-globin gene erythroid-responsive in mouse erythroleukemia cells

CACCC and GATA-1 sequences make the constitutively expressed [alpha]-globin gene erythroid-responsive in mouse erythroleukemia cells Sicong Ren , Jihong Li and George F. Atweh *

Department of Medicine and Brookdale Center for Molecular Biology, Mount Sinai School of Medicine, New York , NY 10029, USA

Received August 31, 1995; Revised and Accepted November 30, 1995

ABSTRACT

Although the human [alpha] -globin and [beta] -globin genes are co-regulated in adult life, they achieve the same end by very different mechanisms. For example, a transfected [beta] -globin gene is expressed in an inducible manner in mouse erythroleukemia (MEL) cells while a transfected [alpha] -globin gene is constitutively expressed at a high level in induced and uninduced MEL cells. Interestingly, when the [alpha] -globin gene is transferred into MEL cells as part of human chromosome 16, it is appropriately expressed in an inducible manner. We explored the basis for the lack of erythroid-responsiveness of the proximal regulatory elements of the human [alpha] -globin gene. Since the [alpha] -globin gene is the only functional human globin gene that lacks CACCC and GATA-1 motifs, we asked whether their addition to the [alpha] -globin promoter would make the gene erythroid-responsive in MEL cells. The addition of each of these binding sites to the [alpha] -globin promoter separately did not result in inducibility in MEL cells. However, when both sites were added together, the [alpha] -globin gene became inducible in MEL cells. This suggests that erythroid non-responsiveness of the [alpha] -globin gene results from the lack of erythroid binding sites and is not necessarily a function of the constitutively active, GC rich promoter.

INTRODUCTION

The different genes of the human [alpha]- and [beta]-globin gene clusters are coordinately regulated to produce embryonic, fetal and adult hemoglobins at specific developmental stages ( 1 , 2 ). In the adult stage, the [alpha]-globin and [beta]-globin genes express equivalent levels of globin chains to produce Hb A, the major adult hemoglobin. The molecular basis of the coordinate regulation of these two genes has been the subject of intense scrutiny. These studies have identified a number of important and unexpected differences between the [alpha]- and [beta]-globin genes: (i) the [alpha]- and [beta]-globin genes are present on different chromosomes. The [alpha]-globin gene is present on chromosome 16 ( 3 ) while the [beta]-globin gene is present on chromosome 11 ( 4 ); (ii) there are four copies of the [alpha]-globin gene in the diploid human genome and only two copies of the [beta]-globin gene ( 5 , 6 ); (iii) whereas the general intron-exon structure of the [alpha]-globin and [beta]-globin genes is similar, there is very little homology between the proximal regulatory elements of the two genes; (iv) the [alpha]-globin gene is located in a GC rich domain while the [beta]-globin gene is present in an AT rich domain ( 7 ); (v) the [alpha]-globin promoter is constitutively hypomethylated in all cell types ( 8 , 9 ) while the [beta]-globin promoter is heavily methylated in non-expressing cells ( 10 - 12 ); (vi) the [beta]-like globin gene cluster is in an open chromatin domain only in erythroid cells while the [alpha]-like globin gene cluster is located within a larger chromatin domain that is open in all cell types ( 13 ). (vii) The [beta]-globin gene is not expressed efficiently in heterologous cells unless it is linked to a viral enhancer ( 14 - 16 ). In contrast, the [alpha]-globin gene is expressed constitutively in all cell types regardless of the presence of a linked viral enhancer ( 14 , 15 , 17 ); (viii) a stably integrated human [beta]-globin gene is expressed in an inducible manner in mouse erythroleukemia (MEL) cells ( 18 , 19 ) while the [alpha]-globin gene is highly expressed in a constitutive and non-inducible manner ( 18 ); (ix) the human [beta]-globin gene with its immediate flanking sequences is expressed in a tissue and developmental stage-specific manner when inserted in the genome of a transgenic mouse ( 20 , 21 ). In contrast, the [alpha]-globin gene with its immediate flanking sequences is not expressed in any tissue in transgenic mice ( 22 - 24 ); (x) both the [alpha]-globin and [beta]-globin genes are under the control of distant major regulatory elements known as locus control regions (LCRs). The [beta]LCR consists of four hypersensitive sites (HS1-HS4) ( 25 - 27 ) that have different activities at different developmental stages ( 28 ). In contrast, all the activity of the [alpha]LCR appears to be localized to a single discreet hypersensitive site known as HS-40 ( 29 , 30 ).

We had previously explored the molecular basis for the differences in the behavior of the [alpha]- and [beta]-globin genes in transient expression systems. We showed that [alpha]-globin promoter sequences upstream of the cap site are not sufficient to account for the constitutive activity of the [alpha]-globin gene in erythroid and non-erythroid cells ( 31 ). We demonstrated that sequences immediately downstream from the cap site are essential for the full enhancer-independent activity of the [alpha]-globin gene promoter ( 31 ). We also showed that an extended [alpha]-globin promoter that includes sequences from the structural gene is more responsive to the enhancing activity of the [alpha]LCR than a promoter element that is limited to 5' flanking sequences ( 32 ). James-Pederson et al. have recently made similar observations during their study of the regulation of the rabbit [alpha]-globin gene ( 33 ). These studies of the human and rabbit [alpha]-globin genes highlight another feature that the [alpha]-globin promoter shares with promoters of many housekeeping genes, i.e. extension of the promoter element into the structural sequences of the gene ( 34 - 36 ).

A number of erythroid-specific transcription factors play important roles in mediating the activity of the proximal and distal regulatory elements of the different globin genes. The binding sites for two of these erythroid transcription factors, GATA-1 and EKLF [an erythroid-specific transcription factor that binds CACCC sequences ( 37 )] are present in the proximal regulatory element of every human globin gene except the [alpha]-globin gene. It is not clear whether the lack of erythroid-responsiveness of the human [alpha]-globin gene in MEL cells is dictated by the `housekeeping' properties of its promoter or by the lack of GATA-1 and CACCC sites in its promoter. We used inducibility in MEL cells as a surrogate marker for erythroid-responsiveness. We asked whether the insertion of these binding sites in the [alpha]-globin promoter would allow the gene to respond to erythroid differentiation of MEL cells by increasing its level of expression beyond the constitutively high basal level of uninduced cells. The experiments described in this report show that addition of GATA-1 and CACCC sequences, together but not separately, can make the [alpha]-globin promoter inducible in MEL cells. This suggests that the lack of erythroid-responsiveness of the [alpha]-globin gene is not necessarily a result of its `housekeeping' promoter which maintains it in an active state in homologous and heterologous cells but more likely a result of the absence of binding sites for erythroid-specific transcription factors in its promoter. The implications of these experimental observations will be discussed within the context of our current understanding of the regulated expression of the [alpha]-globin gene.

MATERIALS AND METHODS

Plasmid constructions

A 1.5 kilobase (kb) Pst I fragment that carries the human [alpha]1-globin gene was cloned into the Pst I site of the Bluescript II KS ® plasmid vector (Stratagene, La Jolla, CA). Upstream 5' flanking sequences were deleted from the cloned [alpha]-globin gene by exonuclease III digestion according to instructions provided with the Erase-a-Base ® kit (Promega, Madison, WI). Initially, the plasmid carrying the [alpha]-globin gene was digested with Xba I and the 5' ends were protected by [alpha]-phosphorothioate incorporation. The plasmid DNA was then digested with Bam HI followed by timed exonuclease III digestions. A plasmid library was generated from these deletion mutants and several unique clones with different sized deletions were identified. Expression from these truncated promoter constructs was analyzed in a stable MEL cell expression system as previously described ( 38 ). Based on the results of this preliminary analysis, a construct which retained 142 bp of 5' flanking sequences ( [alpha] -142 ) was selected for use as a backbone for the generation of all constructs used in this study (Fig. 1 ).


Figure 1 . Schematic illustration of the [alpha]-globin expression constructs. The solid boxes represent the transcribed sequences of the human [alpha]-globin gene. The 5' flanking sequences, including the TATA and CCAAT boxes, are displayed as thin lines. The insertions of the duplicated GATA-1 and CACCC sequences upstream of position [alpha] -142 of the [alpha]-globin promoter are also shown.

A 30 base pair (bp) double-stranded oligonucleotide was synthesized which corresponds to a GATA-1 site previously identified in the enhancer downstream of the human A [gamma]-globin gene (5'-CTCCCAACTGACCTTATCTGTGGGGGAGGC-3') ( 38 ). This synthetic GATA-1 sequence was cloned at the Sac I site upstream of the [alpha]-globin promoter of [alpha] -142 . A construct that carried two copies of this GATA-1 oligonucleotide was identified by DNA sequence analysis (GG[alpha] -142 ) (Fig. 1 ). A similar construct was generated by cloning a 20 bp double-stranded oligonucleotide corresponding to the CACCC sequence of the human [beta]-globin gene (5'-GAGCCACACCCTAGGGTTGG-3') at the Sac I site of [alpha] -142 . A construct that carried two copies of this CACCC oligonucleotide was also identified by DNA sequence analysis (CC[alpha] -142 ) (Fig. 1 ). A third construct was generated by cloning two copies of the same CACCC oligonucleotide at a Sac II site immediately upstream of the GATA-1 sequences of GG[alpha] -142 . This construct that carried two copies of CACCC and two copies of GATA-1 was named CCGG[alpha] -142 (Fig. 1 ). The last construct was generated by cloning a 255 bp [alpha]LCR fragment that we described earlier ( 32 ) at the Sac I site of [alpha] -142 ([alpha]LCR[alpha] -142 ) (Fig. 1 ).

Generation of stable cell lines

Stable cell lines were generated by transfecting MEL cells with each of the five plasmid expression constructs shown in Figure 1 . DNA (20 [mu]g) from each construct was co-transfected with 2 [mu]g of a plasmid carrying the neomycin resistance gene ( 39 ) by electroporation into MEL cells as previously described ( 32 ). The transfected cells were plated for two weeks in selective media which contained G418 at an active concentration of 400 [mu]g/ml. Pools of transfected cells were established by expanding the G418-resistant cells that survived after 2 weeks in selective medium. Single cell clones were isolated from these pools by limiting dilution.


Figure 2 . Expression of the human [alpha]-globin gene in MEL cells. The autoradiograph represents a quantitative S1 assay of one pool (P) and six individual clones (1-6) of MEL cells transfected with the [alpha] -142 expression construct. The lane marked (K) is a control containing RNA from human K562 cells. Five micrograms of cytoplasmic RNA from transfected MEL cells and 5 [mu]g of RNA from K562 cells were used in the S1 hybridization experiments. (U) stands for uninduced cells and (I) for DMSO-induced cells. The location of the 97 nt probe fragment protected by [alpha]-globin mRNA is marked `[alpha]'.

Analysis of globin gene expression in transfected cells

Pools and clones of G418-resistant cells were induced to differentiate by exposure to 1.4% dimethyl sulfoxide (DMSO) for 3 days as previously described ( 32 ). The success of each induction was confirmed by a marked increase in the level of expression of the murine [beta] maj globin mRNA as previously described ( 32 ). DNA was isolated from these cells and used in Southern blot analyses to quantify the number of integrated copies of the transfected [alpha]-globin genes. Ten micrograms of each DNA were digested with Hin dIII and probed with a 1.5 kb Pst I fragment that carries the human [alpha]-globin gene. Cytoplasmic RNAs were isolated from induced and uninduced cells as described by Favaloro et al. ( 40 ) and analyzed for human [alpha]-globin gene expression by S1 nuclease assays as previously described ( 41 ). The 3' end-labeled probe consisted of a 391 bp Nco I/ Hin dIII fragment of the [alpha]-globin gene of which 97 nt are protected by [alpha]-globin mRNA ( 42 ). Since the basal level of expression of the human [alpha]-globin gene in MEL cells was very high, we only used 3-5 [mu]g of cytoplasmic RNA in each S1 assay to ensure that all hybridizations will take place in DNA probe excess. We also included 5 [mu]g of RNA from human K562 cells as a control in every experiment to be able to make comparisons across assays. Each S1 assay was repeated at least three times with consistent findings. Autoradiographs of Southern blots and S1 assays were analyzed by densitometric scanning to determine the number of integrated copies and the level of expression of the [alpha]-globin gene respectively.

We also analyzed the effect of CACCC and GATA-1 sequences on the activity of the [alpha]-globin gene in fibroblasts. NIH 3T3 cells were transiently transfected by calcium phosphate-DNA coprecipitation as previously described ( 41 ). Twenty micrograms of either the [alpha] -142 or the CCGG[alpha] -142 construct were co-transfected with a control construct consisting of a human [gamma]-globin gene linked to the SV40 enhancer ( 42 ). The levels of expression of the [alpha]- and [gamma]-globin genes were assessed by an S1 nuclease protection assay as previously described ( 42 ). The relative activity of the two [alpha]-globin gene constructs in fibroblasts was expressed as the ratio of the densitometric signals corresponding to [alpha]-globin mRNA over [gamma]-globin mRNA.


Figure 3 . Effect of GATA-1 sequences on [alpha]-globin expression in MEL cells. The autoradiograph represents a quantitative S1 assay of one pool (P) and six individual clones (1-6) of MEL cells transfected with the GG[alpha] -142 expression construct. The lane marked (K) is a control containing RNA from human K562 cells. Three micrograms of cytoplasmic RNA from transfected MEL cells and 5 [mu]g of RNA from K562 cells were used in the S1 hybridization experiments. (U) stands for uninduced cells and (I) for DMSO-induced cells. The location of the 97 nt probe fragment protected by [alpha]-globin mRNA is marked `[alpha]'.

Graphics

Autoradiographs were imaged using a Silverscan flatbed digital scanner (La Cie, Ltd, Beaverton, OR). Image processing was performed on a Macintosh Quadra 800 (Apple, Cupertino, CA) using Adobe Photoshop (Adobe, Mountain, CA) and Aldus Persuasion (Aldus, Seattle, WA) software. Figures were printed using a XL7700 Digital Continuous Tone Printer (Kodak, Rochester, NY).

RESULTS

We first analyzed the activity of different truncations of the [alpha]-globin promoter by expression assays in stably transfected MEL cells to identify a minimal promoter that retains full constitutive activity. A previous study had shown that an [alpha]-globin promoter truncated to position -87 retains full activity in a transient expression assay in COS cells ( 17 ). The activity of the [alpha] -142 globin construct was found to be essentially identical to the non-truncated [alpha]-globin promoter in induced and uninduced MEL cells (data not shown). Thus, we selected this minimal [alpha] -142 construct as a backbone for the generation of the other expression constructs shown in Figure 1 . By design, these expression constructs carried two copies of the binding sites for CACCC and GATA-1 since these sites are commonly duplicated in globin regulatory elements in vivo .

Figure 2 shows the results of a quantitative S1 assay of [alpha]-globin expression in one pool and six clones of MEL cells transfected with the [alpha] -142 plasmid. Both the pool and the individual clones expressed high levels of human [alpha]-globin mRNA that did not increase further with induction. In contrast, the expression of the endogenous mouse [beta] maj globin genes increased from 20- to 50-fold with induction (data not shown). We analyzed a total of four pools and 10 clones of MEL cells transfected with the [alpha] -142 globin construct. None of the pools or clones analyzed showed inducible expression of the [alpha]-globin gene in MEL cells.

We then investigated the erythroid-responsiveness of an [alpha]-globin gene with two GATA-1 sites inserted in its promoter (GG[alpha] -142 ). Figure 3 shows an autoradiograph of an S1 assay of [alpha]-globin expression in one pool and six clones of MEL cells transfected with the GG [alpha] -142 expression construct. Although the pool and all clones expressed the transfected [alpha]-globin gene at a relatively high basal level, [alpha]-globin mRNA increased with induction in two of the six clones analyzed (Fig. 3 , lanes 2 and 5). The level of induction was 1.7-fold in clone 2 and 3-fold in clone 5. We analyzed a total of three pools and 11 clones of MEL cells transfected with the same construct. Inducible expression was seen in only two of the 11 clones and in none of the three pools analyzed. No correlation was noted between the number of integrated copies of the [alpha]-globin gene and inducibility in MEL cells.

An [alpha]-globin gene with two CACCC sites inserted in its promoter (CC[alpha] -142 ) was analyzed in a similar manner. Figure 4 shows an autoradiograph of an S1 assay of [alpha]-globin expression in one pool and six clones of MEL cells transfected with CC[alpha] -142 . The expression of the human [alpha]-globin gene was not inducible in the pool neither in any of the individual clones. We analyzed a total of two pools and 17 individual clones of MEL cells transfected with CC[alpha] -142 . None of the pools or individual clones showed inducible expression of the human [alpha]-globin gene.


Figure 4 . Effect of CACCC sequences on [alpha]-globin expression in MEL cells. The autoradiograph represents a quantitative S1 assay of one pool (P) and six individual clones (1-6) of MEL cells transfected with the [alpha] -142 expression construct. The lane marked (K) is a control containing RNA from human K562 cells. Five micrograms of cytoplasmic RNA from transfected MEL cells and 5 [mu]g of RNA from K562 cells were used in the S1 hybridization experiments. (U) stands for uninduced cells and (I) for DMSO-induced cells. The location of the 97 nt probe fragment protected by [alpha]-globin mRNA is marked `[alpha]'.

We also investigated the inducibility of an [alpha]-globin gene which carried two GATA-1 and two CACCC sites. Figure 5 shows inducible expression in five out of six individual clones of MEL cells transfected with GGCC[alpha] -142 . A total of six pools and 10 individual clones were analyzed. Of these, four pools and seven clones showed an increase in [alpha]-globin mRNA accumulation with erythroid differentiation of MEL cells. The level of inducibility of the [alpha]-globin gene in these cell lines ranged from 1.5- to 5-fold. Here also, there was no correlation between inducibility and the number of integrated copies of the [alpha]-globin gene in MEL cells.


Figure 5 . Effect of GATA-1 and CACCC sequences on [alpha]-globin expression in MEL cells. The autoradiograph represents a quantitative S1 assay of one pool (P) and six individual clones (1-6) of MEL cells transfected with the [alpha] -142 expression construct. The lane marked (K) is a control containing RNA from human K562 cells. Five micrograms of cytoplasmic RNA from transfected MEL cells and 5 [mu]g of RNA from K562 cells were used in the S1 hybridization experiments. (U) stands for uninduced cells and (I) for DMSO-induced cells. The location of the 97 nt probe fragment protected by [alpha]-globin mRNA is marked `[alpha]'.

For comparison, we analyzed expression from an [alpha] -142 globin gene linked to the [alpha]LCR element ([alpha]LCR[alpha] -142 ). The [alpha]LCR (or HS-40) had previously been shown to give rise to inducible expression of a linked [alpha]-globin gene in MEL cells ( 29 , 43 ). Figure 6 represents a quantitative S1 assay of [alpha]-globin expression in one pool and five clones of MEL cells transfected with the [alpha]LCR [alpha] -142 construct. The pool and all individual clones showed highly inducible expression of the human [alpha]-globin gene. We analyzed a total of three pools and eight clones of MEL cells transfected with the [alpha]LCR[alpha] -142 expression construct. All pools and clones showed inducible expression. The level of induction ranged from 3.3- to 46-fold. There was no direct correlation between the number of integrated copies of the [alpha]-globin gene and the level of [alpha]-globin expression in induced or uninduced cells.

We also asked whether the presence of erythroid-specific binding sites in the promoter of the [alpha]-globin gene would inhibit its `promiscuous' activity in non-erythroid cells. We analyzed the effect of CACCC and GATA-1 sites on the activity of the [alpha]-globin promoter in a transient expression assay in NIH 3T3 cells. In three separate transfection experiments, the ratio of the activity of the CCGG[alpha] -142 gene relative to a co-transfected [gamma]-globin gene was 4.0 while the ratio of the [alpha] -142 gene to the same [gamma]-globin gene was 3.1. This suggests that the presence of erythroid-specific binding sites in the promoter of the [gamma]-globin promoter is not sufficient to restrict its activity to erythroid cells. Similarly, we had shown in a previous study that the [alpha]LCR does not restrict the activity of the [alpha]-globin promoter to erythroid cells ( 32 ).

DISCUSSION

The first experiment described above confirmed the original observations of Charnay et al. that the expression of a transfected human [alpha]-globin gene is not inducible in MEL cells ( 18 ). When we inserted GATA-1 binding sites in the promoter of the [alpha]-globin gene, inducibility was seen in a small minority (two out of 11) of the MEL clones that were analyzed. The significance of this observation is not clear. Inducibility resulting from the presence of GATA-1 sites must be very uncommon since [alpha]-globin expression was not inducible in three different pools, each consisting of 500-1000 individual clones. When we inserted CACCC sites in the promoter of the [alpha]-globin gene, inducibility was not seen in any of the pools or clones that were analyzed. The lack of inducibility of the CC[alpha] -142 and the GG[alpha] -142 constructs is unlikely to be a result of the high basal levels of [alpha]-globin expression in the uninduced cells since the average level of expression in the different uninduced cell lines varied by <20%. In contrast, when the CACCC and GATA-1 sites were added together to the [alpha]-globin promoter, the gene became inducible in seven out of ten clones and four out of six pools. Although these pools were generally of high complexity consisting of a large number of independent clones, it is not clear why the [alpha]-globin gene was inducible in some of the pools but not in others. For this reason, it is always desirable to analyze several pools and an even larger number of individual clones before making statements about inducibility.


Figure 6 . Effect of [alpha]LCR sequences on [alpha]-globin expression in MEL cells. The autoradiograph represents a quantitative S1 assay of one pool (P) and five individual clones (1-5) of MEL cells transfected with the [alpha]LCR[alpha] -142 expression construct. The lane marked (K) is a control containing RNA from human K562 cells. Three micrograms of cytoplasmic RNA from transfected MEL cells and 5 [mu]g of RNA from K562 cells were used in the S1 hybridization experiments. (U) stands for uninduced cells and (I) for DMSO-induced cells. The location of the 97 nt probe fragment protected by [alpha]-globin mRNA is marked `[alpha]'.

The proportion of inducible clones from cells transfected with the CCGG[alpha] -142 globin gene is in the same range that was previously described for the human [beta]-globin gene in MEL cells ( 18 , 19 ). The magnitude of induction, however, appears to be significantly higher with the [beta]-globin gene than with the CCGG[alpha] -144 gene. This is most likely a reflection of the very high basal level of expression of the [alpha]-globin gene in uninduced MEL cells compared to the low basal level of expression of the [beta]-globin gene. In fact, Charnay et al. estimated the basal level of expression of the [alpha]-globin gene in uninduced MEL cells to be equivalent to the level of expression of an induced [beta]-globin gene ( 18 ). The lack of inducibility of both the [alpha]- and [beta]-globin genes in a minority of the transfected cell lines is probably a result of their integration in regions of the genome that prevent them from responding to the erythroid environment of the differentiated MEL cell.

Previous studies by other investigators had shown that the AT rich [beta]-globin promoter requires the presence of both CACCC and GATA-1 sites for inducibility in MEL cells. deBoer et al. first demonstrated that a minimal [beta]-globin promoter which includes CACCC, CAAT and TATA boxes is not inducible in MEL cells ( 44 ). Addition of sequences that included binding sites for CP1 and GATA-1 resulted in inducibility in MEL cells ( 44 ). Walters and Martin refined this analysis further by demonstrating that a TATA box-containing minimal promoter from the rabbit [beta]-globin gene becomes inducible in MEL cells upon the addition of GATA-1 sites linked to either CACCC or NF-E2 ( 45 ). It should be noted that both these studies demonstrated that the combination of CACCC and GATA-1 sites results in inducibility in the context of a minimal promoter originating from a [beta]-globin gene which itself is inducible in MEL cell. In contrast, the experiments described in this report demonstrate that the same binding sites can make the constitutively expressed [alpha]-globin gene inducible in MEL cells.

The level of expression of GATA-1 had been shown to increase with erythroid maturation in the developing mouse in vivo ( 46 ) and with induction of MEL cell differentiation in vitro ( 47 ). However, the experiments described above and those of others ( 45 ) show that the addition of GATA-1 to non-inducible promoters is not sufficient to make them inducible in MEL cells. CACCC sequences have previously been shown to bind both the erythroid factor EKLF ( 37 ) as well as the ubiquitous factor Sp1 ( 48 ). Neither the expression of EKLF nor that of the related Sp1 increase when MEL cells are induced to differentiate ( 37 ). Our experiments show that the addition of CACCC sequences to the [alpha]-globin gene promoter does not result in inducible expression in MEL cells. However, when the CACCC and GATA-1 sequences are added together to the [alpha]-globin promoter, inducible expression is seen in about two thirds of the cell lines. It is interesting to note that with the exception of the [alpha]-globin gene, all the functional human globin genes (i.e. [epsilon], G [gamma], A [gamma], [beta] and [xi] have closely situated GATA-1 and CACCC binding sites. This raises the possibility that physical interaction between GATA-1 and EKLF or GATA-1 and Sp1 may be required for inducibility in MEL cells. If this were indeed the case, then the level of GATA-1 may be the limiting factor in this interaction. When MEL cells are induced to differentiate and the level of GATA-1 increases, the GATA-1-EKLF or the GATA-1-Sp1 complexes may reach the critical concentration that is necessary for the activation of promoters which include both binding sites. This speculation is compatible with previous observations relating to the role of GATA-1 and CACCC sequences in the regulation of the human porphobilinogen deaminase (PBG-D) gene ( 49 ). Mutagenesis of either of these sites individually abolished the activity of the promoter in erythroid cells. More interestingly, when the distance between these sites was progressively increased, the activity of the promoter was progressively reduced ( 49 ) suggesting the possibility of physical interaction between these factors. More recently, Merika and Orkin demonstrated direct physical interaction and functional synergy between GATA-1 and EKLF and also between GATA-1 and Sp1 ( 50 ).

Two other observations made in the course of this study deserve further comment. The first observation relates to the issue of copy-number dependence of globin gene expression in the presence of LCR elements. Our experiments show that the LCR does not make the expression of a linked [alpha]-globin gene copy-number dependent in MEL cells. This is in agreement with observations in transgenic mice that the [alpha]LCR (or HS-40) is not sufficient to make the expression of a linked [alpha]-globin gene copy-number dependent ( 51 , 52 ). The second is that even though the addition of CACCC and GATA-1 sites can make the [alpha]-globin gene erythroid-responsive in MEL cells, their combined effects are distinctly different from those of the [alpha]LCR. The addition of the [alpha]LCR to the [alpha]-globin gene resulted in inducible expression in a position-independent manner (i.e. the gene was inducible in every clone regardless of the position of integration). This was clearly not the case when CACCC and GATA-1 were added together to the [alpha]-globin gene since inducible expression was seen in only two thirds of the clones analyzed. In addition, the magnitude of induction was significantly higher in the presence of the [alpha]LCR (3-49-fold) than in the presence of CACCC and GATA-1 (1.5-5-fold). Thus, even though LCR elements of the [alpha]- and [beta]-globin gene clusters contain CACCC and GATA-1 sites ( 29 , 53 - 56 ), the presence of these sites together is not sufficient to reproduce the full activity of the LCR. Since globin LCR elements also contain NF-E2 binding sites ( 29 , 53 ), it would be interesting to investigate whether the combination of GATA-1, CACCC and NF-E2 could account for the full activity of a locus control region.

One of the most important unanswered questions about the regulation of the [alpha]-globin gene relates to the mechanism responsible for its tissue-specific expression. In other words, what are the factors that restrict the expression of the inherently promiscuous [alpha]-globin gene to erythroid cells in vivo ? Although the [alpha]LCR has been shown to have powerful erythroid-specific enhancing activity ( 32 , 43 , 57 ), this does not provide an explanation for the lack of expression from the constitutively active [alpha]-globin promoter in non-erythroid cells. Charnay et al. suggested many years ago that the state of chromatin (as detected by DNase I hypersensitivity) may be very important for restricting the expression of the [alpha]-globin gene to erythroid cells ( 18 ). Unlike deletions of the [beta]LCR, deletions of the [alpha]LCR do not result in loss of DNase I hypersensitivity of the [alpha]-globin promoter in erythroid cells ( 13 , 58 ). This suggests that the mechanism(s) responsible for the DNase I hypersensitivity of the [alpha]-globin promoter are independent of LCR activity. In addition, unlike CpG islands of housekeeping genes that are typically present in an open chromatin configuration in all cell types, the CpG rich [alpha]-globin promoter is present in a closed configuration in non-erythroid cells ( 59 ). We believe that the identification of the elusive factors which control the chromatin configuration of the [alpha]-globin promoter may be crucial for understanding the mechanism of regulated erythroid-specific expression of the [alpha]-globin gene in vivo.

ACKNOWLEDGEMENTS

We would like to thank Dr James Bieker for helpful discussions during the course of this research. We are grateful for the excellent secretarial assistance of Migdalia Torrres. This research was supported by a PHS grant to G.F.A. from NIH (HL42919) and by a GCRC grant (MO1-RR00071) from NIH to the Mount Sinai School of Medicine.

REFERENCES

1 Collins,F.S. and Weissman,S.M. (1984) Prog. Nucleic Acid Res. Mol. Biol., 31, 315-462. MEDLINE Abstract

2 Bunn,H.F. and Forget,B.G. (1986) Hemoglobin: Molecular, Genetic and Clinical Aspects. Saunders, Philadelphia.

3 Deisseroth,A., Nienhuis,A., Turner,P., Velez,R., Anderson,W.F., Ruddle,F., Lawrence,J., Creagan,R. and Kucherlapati,R. (1977) Cell, 12, 205-218. MEDLINE Abstract

4 Deisseroth,A., Nienhuis,A., Lawrence,J., Giles,R., Turner,P. and Ruddle,F.H. (1978) Proc. Natl. Acad. Sci. USA, 75, 1456-1460. MEDLINE Abstract

5 Lauer,J., Shen,C.K.J. and Maniatis,T. (1980) Cell, 20, 119-130. MEDLINE Abstract

6 Fritsch,E.F., Lawn,R.M. and Maniatis,T. (1980) Cell, 19, 959-972. MEDLINE Abstract

7 Bernardi,G., Olofsson,B., Filipski,J., Zerial,M., Salinas,J., Cuny,G., Meunier-Rotival,M. and Rodier,F. (1985) Science, 228, 953-958. MEDLINE Abstract

8 Ghodsian-Fischel,N., Nicholls,R.D. and Higgs,D.R. (1987) Nucleic Acids Res., 15, 9215-9225.

9 Bird,A.P., Taggart,M.H., Nicholls,R.D. and Higgs,D.R. (1987) EMBO J., 6, 999-1004. MEDLINE Abstract

10 Mavilio,F., Giampaolo,A., Care,A., Migliaccio,G., Calandrini,M., Russo,G., Pagliardi,G.L., Mastroberardino,G., Marinucci,M. and Peschle,C. (1983) Proc. Natl. Acad. Sci. USA, 80, 6907-6911. MEDLINE Abstract

11 van der Ploeg,L.H. and Flavell,R.A. (1980) Cell, 19, 947-958. MEDLINE Abstract

12 Shen,C.K. and Maniatis,T. (1980) Proc. Natl. Acad. Sci. USA, 77, 6634-6638. MEDLINE Abstract

13 Craddock,C.F., Vyas,P., Sharpe,J.A., Ayyub,H., Wood,W.G. and Higgs,D.R. (1995) EMBO J., 14, 1718-1726. MEDLINE Abstract

14 Humphries,R.K., Ley,T., Turner,P., Moulton,A.D. and Nienhuis,A.W. (1982) Cell, 30, 173-183. MEDLINE Abstract

15 Treisman,R., Green,M.R. and Maniatis,T. (1983) Proc. Natl. Acad. Sci. USA, 80, 7428-7432. MEDLINE Abstract

16 Banerji,J., Rusconi,S. and Schaffner,W. (1981) Cell, 27, 299-308. MEDLINE Abstract

17 Mellon,P., Parker,V., Gluzman,Y. and Maniatis,T. (1981) Cell, 27, 279-288. MEDLINE Abstract

18 Charnay,P., Treisman,R., Mellon,P., Chao,M., Axel,R. and Maniatis,R. (1984) Cell, 38, 251-263. MEDLINE Abstract

19 Wright,S., Rosenthal,A., Flavell,R. and Grosveld,F. (1984) Cell, 38, 265-273. MEDLINE Abstract

20 Costantini,F., Radice,G., Magram,J., Stamatoyannopoulos,G., Papayannopoulou,T. and Chada,K. (1985) Cold Spring Harbor Symp. Quant. Biol., 50, 361-370.

21 Townes,T.M., Lingrel,J.B., Chen,H.Y., Brinster,R.L. and Palmita,R.D. (1985) EMBO J., 7, 1715.

22 Palmiter,R.D. and Brinster,R.L. (1986) Annu. Rev. Genet., 20, 465-499. MEDLINE Abstract

23 Ryan,T.M., Behringer,R.R., Townes,T.M., Palmiter,R.D. and Brinster,R.L. (1989) Proc. Natl. Acad. Sci. USA, 86, 37-41. MEDLINE Abstract

24 Hanscombe,O., Vidal,M., Kaeda,J., Luzzatto,L., Greaves,D.R. and Grosveld,F. (1989) Genes Dev., 3, 1572-1581. MEDLINE Abstract

25 Tuan,D. and London,I.M. (1984) Proc. Natl. Acad. Sci. USA, 81, 2718-2722. MEDLINE Abstract

26 Grosveld,F., van Assendelft,G.B., Greaves,D.R. and Kollias,G. (1987) Cell, 51, 975. MEDLINE Abstract

27 Forrester,W.C., Takegawa,S., Papayannopoulou,G., Stamatoyannopoulos,G. and Groudine,M. (1987) Nucleic Acids Res., 15, 10159-10177. MEDLINE Abstract

28 Fraser,P., Pruzina,S., Antoniou,M. and Grosveld,F. (1993) Genes Dev., 7, 106-113. MEDLINE Abstract

29 Jarman,A.P., Wood,W.G., Sharpe,J.A., Gourdon,G., Ayyub,H. and Higgs,D.R. (1991) Mol. Cell. Biol., 11, 4679-4689. MEDLINE Abstract

30 Sharpe,J.A., Summerhill,R.J., Vyas,P., Gourdon,G., Higgs,D.R. and Wood,W.G. (1993) Blood, 82, 1666-1671. MEDLINE Abstract

31 Brickner,H.E., Zhu,X.X. and Atweh,G.F. (1991) J. Biol. Chem., 266, 21004-21010. MEDLINE Abstract

32 Ren,S., Luo,X.N. and Atweh,G.F. (1993) Blood, 81, 1058-1066.

33 James-Pederson,M., Yost,S., Shewchuk,B., Zeigler,T., Miller,R. and Hardison,R. (1995) J. Biol. Chem., 270, 3965-3973.

34 Chung,S. and Perry,R.P. (1989) Mol. Cell Biol., 9, 2075-2082. MEDLINE Abstract

35 Farnham,P.J. and Means,A.L. (1990) Mol. Cell. Biol., 10, 1390-1398. MEDLINE Abstract

36 Yang,J.Q., Remmers,E.F. and Marcu,K.B. (1986) EMBO J., 5, 3553-3562. MEDLINE Abstract

37 Miller,I.J. and Bieker,J.J. (1993) Mol. Cell. Biol., 13, 2776-2786. MEDLINE Abstract

38 Balta,G., Brickner,H.E., Takegawa,S., Kazazian,H.H., Papayannopoulou,T., Forget,B.G. and Atweh,G.F. (1994) Blood, 83, 3727-3737. MEDLINE Abstract

39 Carel,J.C., Frazier,B., Ley,T.J. and Holers,V.M. (1989) J. Immunol., 143, 923-930. MEDLINE Abstract

40 Favalaro,J., Treisman,R. and Kamen,R. (1980) Methods Enzymol., 65, 718-749. MEDLINE Abstract

41 Atweh,G.F., Anagnou,N.P., Shearin,J., Forget,B.G. and Kauffman,R.E. (1985) Nucleic Acids Res., 13, 777-790. MEDLINE Abstract

42 Atweh,G.F., Liu,J.M., Brickner,H.E. and Zhu,X.X. (1988) Mol. Cell. Biol., 8, 5047-5051. MEDLINE Abstract

43 Higgs,D.R., Wood,W.G., Jarman,A.P., Sharpe,J., Lida,J., Pretorius,I.M. and Ayyub,H. (1990) Gene Dev., 4, 1588-1601.

44 deBoer,E., Antoniou,M., Mignotte,V., Wall,L. and Grosveld,F. (1988) EMBO J., 7, 4203-4212. MEDLINE Abstract

45 Walters,M. and Martin,D.I.K. (1992) Proc. Natl. Acad. Sci. USA, 89, 10444-10448. MEDLINE Abstract

46 Whitelaw,E., Tsai,S.F., Hogben,P. and Orkin,S.H. (1990) Mol. Cell. Biol., 10, 6596-6606. MEDLINE Abstract

47 Tsai,S.F., Martin,D.I.K., Zon,L.I., D'Andrea,A.D., Wong,G.G. and Orkin,S.H. (1989) Nature, 339, 446-451. MEDLINE Abstract

48 Hartzog,G.A. and Myers,R.M. (1993) Mol. Cell. Biol., 13, 44-56. MEDLINE Abstract

49 Frampton,J., Walker,M., Plumb,M. and Harrison,P.R. (1990) Mol. Cell. Biol., 10, 3838-3842. MEDLINE Abstract

50 Merika,M. and Orkin,S.H. (1995) Mol. Cell. Biol., 15, 2437-2447. MEDLINE Abstract

51 Sharpe,J.A., Wells,D.J., Whitelaw,E., Vyas,P., Higgs,D.R. and Wood,W.G. (1993) Proc. Natl. Acad. Sci. USA, 90, 11262-11266. MEDLINE Abstract

52 Gourdon,G., Sharpe,J.A., Wells,D., Wood,W.G. and Higgs,D.R. (1994) Nucleic Acids Res., 22, 4139-4147. MEDLINE Abstract

53 Strauss,E.C., Andrews,N.C., Higgs,D.R. and Orkin,S.H. (1992) Mol. Cell. Biol., 12, 2135-2142. MEDLINE Abstract

54 Ikuta,T. and Kan,Y.W. (1991) Proc. Natl. Acad. Sci. USA, 88, 10188-10192. MEDLINE Abstract

55 Talbot,D., Philipsen,S., Fraser,P. and Grosveld,F. (1990) EMBO J., 9, 2169-2178. MEDLINE Abstract

56 Strauss,E.C. and Orkin,S.H. (1992) Proc. Natl. Acad. Sci. USA, 89, 5809-5813. MEDLINE Abstract

57 Pondel,M.D., George,M. and Proudfoot,N.J. (1992) Nucleic Acids Res., 20, 237-243. MEDLINE Abstract

58 Bernet,A., Sabatier,S., Picketts,D.J., Ouazana,R., Morle,F., Higgs,D.R. and Godet,J. (1995) Blood, 86, 1202-1211. MEDLINE Abstract

59 Yagi,M., Gelinas,R., Elder,J.T., Peretz,M., Papayannopoulou,T., Stamatoyannopoulos,G. and Groudine,M. (1986) Mol. Cell. Biol., 6, 1108-1116. MEDLINE Abstract


Return

* To whom correspondence should be addressed at: Division of Hematology, Box 1079, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. C. Mahajan and S. M. Weissman
DNA-dependent adenosine triphosphatase (helicaselike transcription factor) activates beta -globin transcription in K562 cells
Blood, January 1, 2002; 99(1): 348 - 356.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
H. Luo, A. Chaudhuri, K. R. Johnson, K. Neote, V. Zbrzezna, Y. He, and A. O. Pogo
Cloning, Characterization, and Mapping of a Murine Promiscuous Chemokine Receptor Gene: Homolog of the Human Duffy Gene
Genome Res., September 1, 1997; 7(9): 932 - 941.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (109K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Ren, S
Right arrow Articles by Atweh, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, S
Right arrow Articles by Atweh, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?